Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers have made a breakthrough in more precisely targeting drugs to cancers. Using ultrasound and lipid drug carriers (liposomes), a multi-disciplinary team of biomedical engineers, oncologists, radiologists and anaesthetists at the University of Oxford have developed a new way to improve the targeting of cancer drugs to tumours.

None © Celsion

Meet the lead author of the study

  • Paul Lyon
    Paul Lyon

    Senior Research Fellow in Interventional Oncology

Similar stories

Major new initiative for type 1 diabetes research

The University of Oxford has received a £10 million donation from the Bukhman Foundation to establish the Bukhman Centre for Research Excellence in Type 1 Diabetes, alongside new academic posts and scholarships.